Table 4 Multivariate analysis of overall survival and tumor budding using ITBCC scores (no buds/any buds) in endometrial cancer.
From: Prognostic impact of tumor budding in endometrial carcinoma within distinct molecular subgroups
Feature | HR (95% CI) | P value |
|---|---|---|
ITBCC | ||
No buds | 1.0 | 0.0634 |
Any buds | 1.63 (0.9–2.7) | |
T stage | ||
T1–2 | 1.0 | 0.0151 |
T3–4 | 2.4 (1.2–4.9) | |
N stage | ||
N0 | 1.0 | 0.0277 |
N1 | 2.03 (1.1–3.8) | |
M stage | ||
M0 | 1.0 | 0.1374 |
M1 | 1.84 (0.8–4.2) | |
L stage | ||
L0 | 1.0 | 0.4897 |
L1 | 0.8 (0.4–1.5) | |
V stage | ||
V0 | 1.0 | 0.2536 |
V1 | 1.37 (0.8–2.3) | |
Tumor grading | ||
G1–2 | 1.0 | 0.0194 |
G3 | 1.55 (1.1–2.2) | |
